# BOSTON SCIENTIFIC CORPORATION (BSX) FY2026 Q1 Balance Sheet

- Company: BOSTON SCIENTIFIC CORPORATION (BSX)
- Period: As of 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-05-01, accession number 0000885725-26-000033
- Page: https://plicit.ai/financials/bsx/fy2026-q1-balance-sheet
- Chart image: https://plicit.ai/charts/bsx-fy2026-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 44,351,000,000 US dollars
- **Current assets**: 8,684,000,000 US dollars
- **Non-current assets**: 35,667,000,000 US dollars
- **Liabilities (calculated)**: 18,247,000,000 US dollars
- **Current liabilities**: 4,571,000,000 US dollars
- **Non-current liabilities**: 13,676,000,000 US dollars
- **Equity**: 26,104,000,000 US dollars
- **Noncontrolling interest**: 240,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Inventories**: 3,117,000,000 US dollars
- **Trade accounts receivable, net**: 3,027,000,000 US dollars
- **Cash and cash equivalents**: 1,453,000,000 US dollars
- **Other current assets**: 729,000,000 US dollars
- **Prepaid income taxes**: 358,000,000 US dollars
- **Goodwill**: 18,536,000,000 US dollars
- **Other intangible assets, net**: 7,060,000,000 US dollars
- **Property, plant and equipment, net**: 4,063,000,000 US dollars
- **Deferred tax assets**: 3,953,000,000 US dollars
- **Other long-term assets**: 2,054,000,000 US dollars
- **Accrued expenses**: 2,514,000,000 US dollars
- **Accounts payable**: 1,141,000,000 US dollars
- **Other current liabilities**: 875,000,000 US dollars
- **Current debt obligations**: 41,000,000 US dollars
- **Long-term debt**: 10,988,000,000 US dollars
- **Other long-term liabilities**: 2,469,000,000 US dollars
- **Deferred tax liabilities**: 219,000,000 US dollars
- **Additional paid-in capital**: 21,584,000,000 US dollars
- **Retained earnings**: 6,912,000,000 US dollars
- **Common stock, $0.01 par value - authorized 2,000,000,000 shares - 1,749,584,151 shares issued as of March 31, 2026 and 1,746,290,165 shares issued as of December 31, 2025**: 17,000,000 US dollars
- **Preferred stock, $0.01 par value - authorized 50,000,000 shares - 0 shares issued as of March 31, 2026 and December 31, 2025**: 0 US dollars
- **Noncontrolling interests**: 240,000,000 US dollars
- **Treasury stock, at cost - 263,289,848 shares as of March 31, 2026 and December 31, 2025**: negative 2,251,000,000 US dollars
- **Accumulated other comprehensive income (loss), net of tax**: negative 398,000,000 US dollars
- **Gross equity (calculated)**: 28,753,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.
- The filed non-current assets lines add up to $35,666.00 M and the non-current assets total is $35,667.00 M; the $1.00 M difference is within the rounding of the filed amounts.